By Matthew Perrone, Tom Murphy, Associated Press
Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread criticism for an initial cost that can reach $56,000 annually.
By Tom Murphy, Associated Press
The Food and Drug Administration has approved new prescribing instructions that are likely to limit use of a controversial new Alzheimer's drug.
By Matthew Perrone, Associated Press
The FDA on Monday approved the first new drug to treat Alzheimer's disease in nearly two decades. Federal health officials said it may help slow the brain-destroying disease's progression, but the approval goes against the agency's independent advisers who said…
By Amna Nawaz, Claire Mufson
The panel of outside experts for the Food and Drug Administration agreed that a pivotal study in patients failed to show “strong evidence” that the drug worked.
By Marilynn Marchione, AP Chief Medical Writer, Matthew Perrone, Associated Press
By Kate McDonald
Nearly 6 million Americans currently live with Alzheimer’s disease, and the number continues to rise. For many, this terminal diagnosis represents the start of a life with limitations. But as a program called Contemporary Journeys shows, it's a life that…
By John Yang, Leah Nagy
In Nashville, the nonprofit Music for Seniors connects the city’s musicians with its older residents in an effort to build community and improve seniors’ quality of life. Now, the organization is teaming up with researchers at Vanderbilt University to see…
By Miles O'Brien
At age 61, Judi Polak is five years into a bleak diagnosis: Alzheimer’s disease. But last year she made medical history in a clinical trial, when a team of scientists, engineers and practitioners deployed a novel device to take aim…
By Karen Weintraub, Scientific American
A new study points toward neuron formation in the human brain’s hippocampus up through the ninth decade of life, which implications for memory and disease.
By Laura Santhanam
Some people in the early stages of Alzheimer's are likely falling through the cracks and developing more advanced symptoms because their illness isn't caught and treated soon enough, according to a new report from the Alzheimer's Association and medical experts.
Support Provided By:
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Additional Support Provided By: